SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-18-063390
Filing Date
2018-12-06
Accepted
2018-12-06 16:43:27
Documents
20
Period of Report
2018-12-06

Document Format Files

Seq Description Document Type Size
1 6-K tv508504_6k.htm 6-K 13539
2 EXHIBIT 99.1 tv508504_ex99-1.htm EX-99.1 27688
3 EXHIBIT 99.2 tv508504_ex99-2.htm EX-99.2 1703998
4 EXHIBIT 99.3 tv508504_ex99-3.htm EX-99.3 5821
5 GRAPHIC tv508504_img01.jpg GRAPHIC 9736
6 GRAPHIC tv508504_img02.jpg GRAPHIC 3843
7 GRAPHIC tv508504_img03.jpg GRAPHIC 24276
8 GRAPHIC tv508504_img04.jpg GRAPHIC 23570
9 GRAPHIC tv508504_img05.jpg GRAPHIC 43190
10 GRAPHIC tv508504_img06.jpg GRAPHIC 41905
11 GRAPHIC tv508504_img07.jpg GRAPHIC 19330
12 GRAPHIC tv508504_img08.jpg GRAPHIC 24702
13 GRAPHIC tv508504_img09.jpg GRAPHIC 30549
14 GRAPHIC tv508504_img10.jpg GRAPHIC 26220
15 GRAPHIC tv508504_img11.jpg GRAPHIC 26231
16 GRAPHIC tv508504_img12.jpg GRAPHIC 23402
17 GRAPHIC tv508504_img13.jpg GRAPHIC 23029
18 GRAPHIC tv508504_img14.jpg GRAPHIC 41612
19 GRAPHIC tv508504_img15.jpg GRAPHIC 7295
20 GRAPHIC image_001.jpg GRAPHIC 121893
  Complete submission text file 0001144204-18-063390.txt   2429801
Mailing Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042
Business Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042 972 (0) 3 7326616
Bioblast Pharma Ltd. (Filer) CIK: 0001596812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36578 | Film No.: 181221185
SIC: 2834 Pharmaceutical Preparations